Thomas A Waldmann, M.D.
National Cancer Institute (NCI) · NCI, NIH
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas A Waldmann, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:46 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT01893775 · Antibody Treatment for Advanced Celiac DiseaseNational Cancer Institute (NCI) · completed · Celiac Disease, Celiac Sprue, Gluten Enteropathy · principal investigator
- Ph1NCT01021059 · A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell CancerNational Cancer Institute (NCI) · completed · Melanoma, Carcinoma, Renal Cell · principal investigator
- Ph2NCT00117845 · Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell LeukemiaNational Cancer Institute (NCI) · terminated · Leukemia, Adult T-Cell · principal investigator
- Ph1NCT00076180 · Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic LeukemiaNational Cancer Institute (NCI) · completed · T-Cell Large Granular Lymphocytic Leukemia, Leukemia, T-Cell Large Granular Lymphocytic · principal investigator
- Ph2NCT00061048 · Campath-1H for Treating Adult T-Cell Leukemia/LymphomaNational Cancer Institute (NCI) · completed · Acute T-Cell Leukemia-Lymphoma · principal investigator
- Ph1NCT00005655 · Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerNational Cancer Institute (NCI) · terminated · Kidney Neoplasm, Lung Neoplasm, Sarcoma · principal investigator
- Ph1/Ph2NCT00001575 · Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid LeukemiaNational Cancer Institute (NCI) · completed · Hodgkin's Disease, Lymphoma, Non-Hodgkin · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.